Article
Apolipoprotein E polymorphism affects the response to pravastatin on plasma apolipoproteins in diabetic patients.
Diabetes research and clinical practice - 1 Apr 1993
Watanabe J, Kobayashi K, Umeda F, Yamauchi T, Mimura K, Nakashima N, Masakado M, Hiramatsu S, Nawata H
Abstract excerpt
In the present study, we examined the levels of plasma lipids and apolipoproteins in patients with non-insulin dependent diabetes mellitus (NIDDM) with hypercholesterolemia in different apolipoprotein E (apo E) phenotypes. We also examined the influences of apo E polymorphism on the response to pravastatin. The patients were divided into three groups, E4/E3, E3/E3, and E3/E2. There were no differences in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.